Auxly Cannabis Group Inc. (TSX.V - XLY) (“Auxly
or the “Company
”) today announced the unveiling of
its “Cannabis 2.0” products in vape, chocolate and chewable formats
which are legally available for sale beginning today under its
signature brands, Kolab Project, Foray and Dosecann. To view
Auxly’s 2.0 product launch video, click here.
“Having our initial suite of Cannabis 2.0
products ready to go on the first day sales are legal in Canada is
a huge milestone for our company," said Hugo Alves, CEO, Auxly.
“Our mission is to make branded cannabis products that consumers
love and grow to trust. Our experts at Dosecann have developed
high-quality vapes, chocolates and chewables with consumer safety
and enjoyment as our top priorities. We are excited to introduce
Canadian consumers to our products and our brands on the launch of
Cannabis 2.0 and will continue to roll out new and innovative
products in the coming quarters as we look to lead, not follow, in
the 2.0 market and beyond."
Auxly’s In-House Brands – Targeting a
Broad Spectrum of Cannabis Consumers
Auxly has taken a consumer-centric approach to
building a winning portfolio of brands and products. Auxly’s four
proprietary brands: Kolab Project, Foray, Dosecann and Robinsons,
address key market segments and multiple price points across
wellness and adult-use markets.
The Company’s initial product portfolio will be
launched under three of the Company's four brands – Kolab Project,
Foray and Dosecann. Outlined in the table below is a breakdown by
brand and format. The launch of the Robinsons brand will coincide
with the release of Robinsons' premium dried flower produced at its
craft indoor facility in Kentville, Nova Scotia. The Company
intends to develop a line of premium cannabis products under the
Robinsons brand based on the output of its Robinsons Outdoor Grow
(announced by the Company on November 15, 2019) located in
Hortonville, Nova Scotia.
A Media Snippet accompanying this announcement
is available by clicking on the image or link below:
*Products expected to be online Q2 2020**
Products expected to be online Q3 2020
View Auxly’s complete product catalogue on the
Company’s website at www.auxly.com or by clicking here.
Diverse Brand Platform and 2.0 Product
Kolab Project is a platform dedicated to art,
design and culture. Its mission is to provide Canadians with a
carefully curated selection of exceptional cannabis products, while
championing high quality, purposeful goods produced in
collaboration with culturally relevant creators. The brand aims to
connect with those actively in the cannabis category that have an
appreciation for the positive impact that art, culture and design
have on humanity.
VapesKolab Project vape pens will be offered in
several different profiles, specifically high-potency THC and CBD
formulations. Kolab Project’s vapes contain only pure, high-grade
cannabis distillate and botanical terpenes and do not contain any
other ingredients. Kolab Project’s THC formulations and terpene
blends were inspired by popular strains and the potency and
terpenes are tailored to a more experienced cannabis consumer.
Kolab Project vape pens will initially be
available as cartridges and disposables in indica, sativa, and
hybrid varieties, as well as a CBD variety in a disposable
Soft ChewsKolab Project’s soft chews are
designed and developed to deliver robust, sophisticated flavours
for the cannabis edible connoisseur. Free from artificial
ingredients or animal products, this curated collection of soft
chews is perfect for anyone seeking a mindful journey outside the
Kolab Project soft chews will be available in
Grapefruit Hibiscus, Lemon Lavender and Apple Green Tea flavours
and in THC-dominant, balanced, and CBD-dominant packs. The chews
are delicious, high quality, vegan and gluten-free. Kolab Project
soft chews are evenly dosed in each piece and conveniently
Foray is an accessible entry point for anybody —
at any stage of their cannabis journey. Designed for the curious,
Foray is an approachable brand that aims to both celebrate and
educate one’s foray into cannabis, ultimately inviting them to see
cannabis differently. The legalization of cannabis in Canada brings
tremendous opportunity to educate and introduce (or reintroduce)
cannabis to a new class of consumers and Foray aims to be a trusted
provider and guide through a consumer’s cannabis experience.
VapesForay brings a range of high-quality vape
products to market in slightly lower THC potency, containing only
high-grade cannabis distillate and carefully selected botanical
terpene blends to ensure a pleasant experience for a consumer’s
entry into the category. Foray vape pens do not contain any other
ingredients. Vape cartridge formats will be available in sativa,
indica, hybrid and balanced formulations, while its disposable
formats will also include a CBD variety.
ChocolatesForay’s chocolates are made
exclusively from premium single origin and Belgian chocolates,
expertly selected and blended to make a consumer’s Foray into
cannabis luxurious and delicious. Made with all-natural ingredients
and no artificial flavours, Foray chocolates will initially come in
three varieties – Dark Chocolate, Vanilla Chai and Salted Caramel.
Foray chocolates will initially be available in 10mg of THC per
square or 2.5mg of THC per four square serving sizes. Additionally,
the Salted Caramel chocolate will be available in a balanced THC
& CBD formulation.
Foray’s Dark chocolate is made with a perfectly
balanced, premium, single origin Mexican chocolate that displays
complex notes of cinnamon, hazelnut, coffee and gingerbread.
Consumers are encouraged to savor their experience as the flavours
of this subtly bittersweet chocolate unfold on their palate.
Foray’s Vanilla Chai chocolate is made with a
single origin Ghanaian chocolate delicately flavoured with chai
spices and vanilla. Also displaying notes of cocoa, red fruit, and
chestnut, this premium chocolate has a rich, creamy mouthfeel.
Foray’s Salted Caramel chocolate is made from an
expertly selected blend of premium white and milk chocolates,
enhanced with notes of rich caramel with a subtle, salty finish.
With a balanced profile of THC and CBD, this chocolate is a perfect
Soft ChewsForay’s soft chews are crafted to
deliver deliciously bright, juicy flavours. These pectin-based
chews, free from any artificial ingredients or animal products,
offer a range of potencies so they can be enjoyed by anyone.
Foray soft chews will initially be available in
Raspberry Vanilla, Peach Mango and Pineapple Orange flavours in
THC-dominant, balanced, and CBD-dominant packs.
Like Kolab Project’s soft chews, Foray’s soft
chews are made with the highest quality traceable, vegan
ingredients combined with ultra-pure cannabis distillate produced
in-house at Dosecann. Foray's rich soft chews offer consumers
unparalleled flavour and the security that each piece has been
precisely dosed to ensure a satisfying experience.
Dosecann is a wellness brand built on pillars of
quality, safety and efficacy. Backed by science and advanced
research and development, Dosecann products are driving today’s
innovation and establishing tomorrow’s standards. Dosecann is
cannabis – down to a science™.
Dosecann’s “Cannabis 1.0” oil in bottle and
spray formats are currently available for sale, with capsule and
lozenge formats expected in Q2 2020 and topicals in Q3 2020.
Auxly Cares About Consumer
Auxly is committed to ensuring consumers have
access to quality products they can trust. For that reason, Auxly’s
Safety Board, on which Imperial Brands PLC’s Group Science and
Regulatory Affairs Director sits, oversees our entire product
development life cycle, carefully evaluates and monitors all of our
products before and after they are released for sale and ensures
that consumers have access to clear and accurate information on
Like all of Auxly’s branded cannabis products,
its vapes have been developed with quality, safety and efficacy at
the heart of the product development process. The Company has gone
above and beyond applicable regulatory requirements with both its
hardware and its formulations, including conducting voluntary
emissions testing at a leading third-party lab, to earn the trust
of Canadian consumers.
All of Auxly’s products are formulated and
manufactured at Dosecann, Auxly’s commercial scale extraction,
analytical testing, product development and manufacturing hub
located in Charlottetown, Prince Edward Island. Dosecann, in
collaboration with KGK Science Inc., the Company’s wholly-owned
contract research organization, will continue to push industry
standards in terms of product safety, quality, efficacy and
ON BEHALF OF THE BOARD
"Hugo Alves” CEO
About Auxly Cannabis Group Inc. (TSX.V:
XLY) (OTCQX: CBWTF)
Auxly is an international cannabis company
dedicated to bringing innovative, effective, and high-quality
cannabis products to the medical, wellness and adult-use markets.
Auxly's experienced team of industry first-movers and enterprising
visionaries has secured a diversified supply of raw cannabis,
strong clinical, scientific and operating capabilities and leading
product research and development infrastructure in order to create
trusted products and brands in an expanding global market.
Learn more at www.auxly.com and stay up to date at Twitter:
@AuxlyGroup; Instagram: @auxlygroup; Facebook:
@auxlygroup; LinkedIn: company/auxlygroup/.
For investor enquiries please contact our
Investor Relations Team: Email: IR@auxly.comPhone:
For media enquiries or to set up an interview
please contact:Email: email@example.com
Notice Regarding Forward Looking
This news release contains certain
"forward-looking information" within the meaning of applicable
Canadian securities law. Forward-looking information is frequently
characterized by words such as "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed" and other similar words, or
information that certain events or conditions "may" or "will"
occur. This information is only a prediction. Various assumptions
were used in drawing the conclusions or making the projections
contained in the forward-looking information throughout this news
release. Forward-looking information includes, but is not limited
to: the successful production and launch of the Company's new
derivative products; the timeline for the launch of additional
product formats; the Company's execution of its product development
and commercialization strategy; consumer preferences; political
change, future legislative and regulatory developments involving
cannabis and cannabis products; and competition and other risks
affecting the Company in particular and the cannabis industry
A number of factors could cause actual results
to differ materially from a conclusion, forecast or projection
contained in the forward-looking information in this release
including, but not limited to, whether: Kolab Project and Dosecann
are able to maintain their sales licenses and are able to obtain
and maintain all other necessary governmental and regulatory
authorizations and permits to conduct business; the acceptance and
demand for future Company products by consumers and provincial
purchasers; and general economic, financial market, regulatory and
political conditions in which the Company operates will remain the
same. Additional risk factors are disclosed in the revised annual
information form of the Company for the financial year ended
December 31, 2017 dated May 24, 2018.
New factors emerge from time to time, and it is
not possible for management to predict all of those factors or to
assess in advance the impact of each such factor on the Company's
business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those
contained in any forward-looking information. The forward-looking
information in this release is based on information currently
available and what management believes are reasonable assumptions.
Forward-looking information speaks only to such assumptions as of
the date of this release. In addition, this release may contain
forward-looking information attributed to third party industry
sources, the accuracy of which has not been verified by the
Company. The purpose of forward-looking information is to provide
the reader with a description of management's expectations, and
such forward-looking information may not be appropriate for any
other purpose. Readers should not place undue reliance on
forward-looking information contained in this release.
The forward-looking information contained in
this release is expressly qualified by the foregoing cautionary
statements and is made as of the date of this release. Except as
may be required by applicable securities laws, the Company does not
undertake any obligation to publicly update or revise any
forward-looking information to reflect events or circumstances
after the date of this release or to reflect the occurrence of
unanticipated events, whether as a result of new information,
future events or results, or otherwise.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Three photos accompanying this announcement are available
Auxly Cannabis (TSXV:XLY)
Historical Stock Chart
From Sep 2021 to Oct 2021
Auxly Cannabis (TSXV:XLY)
Historical Stock Chart
From Oct 2020 to Oct 2021